Restor3D Outcomes Registry: Patient-specific Joint Implants
Official title: The restor3d Outcomes Registry: Tracking Patient Recovery After Joint Replacement
Run by Restor3D · NCT07563803 · Data updated 2026-11-12
This registry tests how patients with FDA-cleared restor3d patient-specific implants fare over up to 5 years, by collecting their own reports on pain, function and quality of life after joint replacement surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2250 (estimated) |
| Sponsor | Restor3D Industry-sponsored |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | October 15, 2026 |
| Main results expected | October 15, 2032 |
| Study ends | October 15, 2032 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07563803 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who have been prescribed and received an FDA-cleared or approved restor3d patient-specific orthopedic implant and consent to participate, with English proficiency.
✕Probably not a fit
Patients receiving non–restor3d implants, implants not FDA-cleared/approved, outside the defined cohorts, or who do not consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The restor3d Outcomes Registry is a prospective, decentralized, longitudinal observational study enrolling adults who have received a restor3d patient-specific orthopedic implant across multiple joint cohorts (knee, hip, foot & ankle, shoulder). Participants complete electronic patient-reported outcomes before surgery and at defined intervals up to five years postoperatively, without in-person visits. The study uses a master protocol with joint-specific appendices to standardize data collection and aims to quantify changes in pain, function, quality of life, and satisfaction while establishing real-world benchmarks for these implants. Enrollment is limited to US-based patients receiving FDA-cleared or approved restor3d implants and who speak English to ensure accurate survey completion. Lead sponsor is Restor3D, with no collaborators and a single participating site in Durham, NC.
Why it matters
Potential benefit: If successful, the registry could provide real-world benchmarks for patient-specific implants and help guide future clinical decisions and patient expectations.
How similar studies have gone: Other real-world, patient-reported outcomes registries for orthopedic implants have shown value in tracking long-term outcomes, though this program appears to be specific to restor3d patient-specific implants.
Who can join: the full rules
Show full inclusion / exclusion criteria
Master Protocol Inclusion Criteria: * Age ≥ 18 years * Prescribed an FDA-cleared or approved orthopedic implant manufactured by restor3d, Inc. Master Protocol Exclusion Criteria: * Patient is receiving an implant not manufactured by restor3d * Patient is receiving a restor3d implant that is not FDA-cleared or approved * Patient lives outside the United States * Patient is receiving a restor3d implant that does not use a patient-specific plan, instrumentation or implant * Patient is non-English-speaking (to ensure accurate comprehension and completion of the surveys) * Patient is receiving a restor3d implant outside of the defined implant cohorts * Patient does not provide informed consent
Where it's running
-
Restor3D
Durham, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Kathryn Jackson
- Email: clinicalresearch@restor3d.com
- Phone: 984-248-0533
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
-
Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review
This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.
-
Predicting early mobility after hip or knee replacement using a machine learning model
A machine learning model is being tested to see if it can predict which patients will walk sooner after hip or knee replacement surgery.
-
How consistent ILoA scores are and whether staff retraining improves them
This project will test whether physiotherapists give consistent Iowa Level of Assistance (ILoA) scores for patients after hip or knee arthroplasty or femoral fracture and whether retraining staff makes the scores more consistent.
-
Antigravity treadmill rehabilitation after hip or knee replacement
This project will test whether antigravity or body-weight-supported treadmill training helps people aged 60–75 recover walking, balance, and confidence after hip or knee replacement.
-
Embolization treatment for patients with hereditary bleeding disorders
This study is testing whether a new treatment using tiny particles can help people with hereditary bleeding disorders and joint pain feel better and improve their quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.